Basic Information
ID: ALA4012796
Type: Functional
Description: Antiviral activity against Human rhinovirus A21 infected in human H1HeLa cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay
Organism: rhinovirus A21
Activity Charts
Bioactivity
Activity Types for Assay ALA4012796
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 381.35 | 4.68 | 4.68 |
| 423.72 | 6.81 | 6.81 |
| 369.44 | 4.54 | 4.54 |
| 367.41 | 3.29 | 3.29 |
| 236.29 | 3.09 | 3.09 |
| 367.41 | 3.59 | 3.59 |
| 378.43 | 4.34 | 4.34 |
| 356.40 | 3.54 | 3.54 |
| 350.37 | 3.56 | 3.56 |
| 384.46 | 4.19 | 4.19 |
| 312.39 | 5.18 | 5.18 |
| 369.45 | 3.46 | 3.46 |
| 390.85 | 4.28 | 4.28 |
| 350.37 | 3.56 | 3.56 |
| 398.42 | 4.61 | 4.61 |
| 398.48 | 4.57 | 4.57 |
| 236.29 | 3.09 | 3.09 |
| 299.35 | 4.27 | 4.27 |
| 381.41 | 3.50 | 3.50 |
| 371.41 | 4.36 | 4.36 |
| 222.26 | 2.78 | 2.78 |
| 432.50 | 5.11 | 5.11 |
| 381.43 | 3.60 | 3.60 |
| 364.40 | 3.95 | 3.95 |
| 384.46 | 4.32 | 4.32 |
| 356.40 | 3.62 | 3.62 |
| 342.38 | 3.23 | 3.23 |
| 340.34 | 3.16 | 3.16 |
| 369.45 | 3.51 | 3.51 |
| 336.35 | 3.17 | 3.17 |
| 351.36 | 2.96 | 2.96 |
| 370.43 | 3.93 | 3.93 |
| 298.36 | 4.87 | 4.87 |
| 371.42 | 3.21 | 3.21 |
| 384.46 | 4.32 | 4.32 |
| 390.85 | 4.28 | 4.28 |
| 342.38 | 3.45 | 3.45 |
| 366.37 | 3.27 | 3.27 |
| 384.46 | 4.32 | 4.32 |
| 250.32 | 3.40 | 3.40 |
| 370.43 | 4.01 | 4.01 |